http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2007016313-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f874eb11d4775decc4fd06a6071a4c9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 |
| filingDate | 2006-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd6f4743a07050e600e72d190391ef51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4fe66ebcf403655600f33aaa9f0f782 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe5523f7ed7f57ffeb0b64691494c685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea5743b2a265ab8f4a4f3eb28f5c803e |
| publicationDate | 2008-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2007016313-A |
| titleOfInvention | 2-SUBSTITUTED BENCIMIDAZOLS. |
| abstract | RSV replication inhibitors of formula (I) (see formula (I)) are described as addition salts and stereochemically isomeric forms thereof, wherein Q is hydrogen, C1-6 alkyl optionally substituted with a heterocycle, or Q is C1-6 alkyl substituted with -OR4 and a heterocycle; wherein said heterocycle is oxazolidine, thiazolidine, 1-oxo-thiazolidine, 1,1-dioxothiazolidine, morpholinyl, thiomorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxothiomorpholinyl, hexahydrooxazepine, hexahydro-thiazepine, oxazepine-1-oxazepine , 1-dioxo-hexahydrotiazepine, pyrrolidine, piperidine, homopiperidine or piperazine; whose heterocycle can be substituted with 1 to 2 substituents; each Alq is C1-6 alkanediyl; R1 is Ar2 or piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, tetrahydrofuranyl, thienyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, isothiazolyl, pyrazolyl, isoxazolyl, oxadiazolyl, quinolinyl, quinoxalinyl, benzofuranyl, benzothienyl, benzimidazolyl, benzoxazolyl, benzthiazolyl, pyridopyrididyl, naphthyridinyl, 1H-imidazo [4,5-b] -pyridinyl, 3H-imidazo [4,5-b] -pyridinyl, imidazo [1,2-a] pyridinyl or 2,3- dihydro-1,4-dioxino [2,3-b] pyridyl; R3 is C1-6 hydroxyalkyl C1-6 alkoxy-C1-6 alkyl, cyanoalkyl of C1-6, aminocarbonylalkyl of C1-6, mono- or di-aminocarbonylalkyl of C1-6, carboxylalkyl of C1-6 or alkoxycarbonyl of C1- 6-C1-6 alkyl; R2 is hydrogen or C1-6 alkyl; R3 and R4 are hydrogen, C1-6 alkyl, C1-6 alkylcarbonyl, Ar2carbonyl, Ar2 C1-6 alkylcarbonyl, C1-6 alkylsulfonyl, aminosulfonyl, Ar1sulfonyl, C1-6 alkylsulfonyl, C1-6 alkyloxy C1-6; C1-6 aminoalkyl, mono- or di- amino C1-6 alkyl-C1-6 alkyl, hydroxy C1-6 alkyl, aminocarbonylalkyl C1-6, alkyloxycarbonyl C1-4-alkyl C1-6, hydroxycarbonylalkyl C1 -6, C1-6 aminosulfonylalkyl, Het, Het-C1-6 alkyl, Het-carbonyl, Het-sulfonyl, C1-6 hetalkylsulfonyl or Het-C1-6 alkylcarbonyl; Het is an optionally substituted heterocycle; Pharmaceutical compositions containing compounds of formula (I), and methods for preparing compounds of formula (I). |
| priorityDate | 2005-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 144.